29th Mar 2021. 7.45am
Regency View:
Morning Report – Monday 29th March
FTSE to open at 6,742 (+2 pts)
As the first quarter closes, we expect trading volumes to peak on Wednesday with President Joe Biden is set to outline further spending plans designed to ramp-up the US economic recovery…
The bill, worth an estimated $3 trillion will be targeted on long-term infrastructure, education and childcare spending – partially funded by tax increases. How the market reacts might just set the tone for the negations with Capitol Hill which are likely to dominate the second quarter.
Asian stocks have had a mild start to the week with Hong Kong’s Hang Seng index just slipping into negative territory – setting up a relatively neutral start to European trading.
S&P 500 | +1.66% | Bullish for UK stocks |
Hang Seng | -0.28% | Neutral for UK stocks |
Gold | -0.34% | Neutral for UK stocks |
AUD/JPY | -0.37% | Bearish for UK stocks |
US 10yr Yield | -1.57% | Bullish for UK stocks |
After Thursday’s bullish hammer candle, the market showed strength on Friday with an acceleration of buying on the futures during the later half of US trading – highlighting the market’s willingness to retest the key 6,800 resistance area.
The futures have pulled back towards Friday’s cash market close, potentially creating a second bite at the cherry for traders who wish to ride a move towards resistance.
Final Results |
Dev Clever Hol. (DEV) |
Digitalbox (DBOX) |
Elecosoft (ELCO) |
Globaltrans S (GLTR) |
Impact Health (IHR) |
Quixant (QXT) |
Ten Ent Grp (TEG) |
UK Economic Announcements |
(08:00) Nationwide House Price Index |
International Economic Announcements |
(11:00) Consumer Confidence (EU) |
(11:00) Business Climate Indicator (EU) |
(11:00) Industrial Confidence (EU) |
Don’t have a Regency account yet?
Start receiving our actionable Market Alerts and Analysis with real-time email and SMS alerts throughout your trading day. Simply click below to create your account for free.
Create AccountAny Questions? Please feel free to call 0203 973 8007 or email us at info@regency.capital
Disclaimer:
This research is prepared for general information only and should not be construed as any form of investment advice.